Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
Authors
Keywords
apoC-III, Lipoproteins, Triglycerides, Remnants, CVD
Journal
Current Atherosclerosis Reports
Volume 18, Issue 10, Pages -
Publisher
Springer Nature
Online
2016-09-09
DOI
10.1007/s11883-016-0614-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
- (2016) Børge G. Nordestgaard CIRCULATION RESEARCH
- Novel therapies for severe dyslipidemia originating from human genetics
- (2016) Daniel Gaudet CURRENT OPINION IN LIPIDOLOGY
- Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes
- (2016) Juraj Koska et al. JOURNAL OF LIPID RESEARCH
- Association between Apolipoprotein C-III Gene Polymorphisms and Coronary Heart Disease: A Meta-analysis
- (2016) Jing-Zhan Zhang et al. Aging and Disease
- Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal ObesitySignificance
- (2015) Jan Borén et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Plasma Apolipoprotein C-III Levels, Triglycerides, and Coronary Artery Calcification in Type 2 DiabeticsSignificance
- (2015) Arman Qamar et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Hypertriglyceridemia Associated With Abdominal Obesity: Figure.
- (2015) André C. Carpentier ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- New insights into the pathophysiology of dyslipidemia in type 2 diabetes
- (2015) Marja-Riitta Taskinen et al. ATHEROSCLEROSIS
- Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping
- (2015) I. van den Broek et al. CLINICAL CHEMISTRY
- The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia
- (2015) Frank M. Sacks CURRENT OPINION IN LIPIDOLOGY
- Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes
- (2015) Helen C. Looker et al. DIABETOLOGIA
- APOA5 -1131T>C and APOC3 -455T>C polymorphisms are associated with an increased risk of coronary heart disease
- (2015) Y. Sun et al. GENETICS AND MOLECULAR RESEARCH
- The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis
- (2015) Moritz C. Wyler von Ballmoos et al. Journal of Clinical Lipidology
- Association of APOC3 Loss-of-Function Mutations With Plasma Lipids and Subclinical Atherosclerosis
- (2015) Pradeep Natarajan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoforms
- (2015) Olgica Trenchevska et al. METHODS
- Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
- (2015) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein C-III: From Pathophysiology to Pharmacology
- (2015) Giuseppe Danilo Norata et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides
- (2015) Hussein N. Yassine et al. PLoS One
- Gene Therapy for Hypercholesterolemia
- (2014) Murray W. Huff et al. CIRCULATION RESEARCH
- Postprandial hypertriglyceridemia as a coronary risk factor
- (2014) Jan Borén et al. CLINICA CHIMICA ACTA
- Inhibition of ApoCIII
- (2014) Sophie J. Bernelot Moens et al. CURRENT OPINION IN LIPIDOLOGY
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting APOC3 in the Familial Chylomicronemia Syndrome
- (2014) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans
- (2014) Nicholas J. Timpson et al. Nature Communications
- Apolipoprotein C-III
- (2013) Murray W. Huff et al. CIRCULATION RESEARCH
- Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
- (2013) Mark J. Graham et al. CIRCULATION RESEARCH
- Potential of Proprotein Convertase Subtilisin/Kexin Type 9 Based Therapeutics
- (2013) Evan A. Stein et al. Current Atherosclerosis Reports
- Ectopic lipid storage and insulin resistance: a harmful relationship
- (2013) J. Borén et al. JOURNAL OF INTERNAL MEDICINE
- A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates
- (2013) Ioanna Tachmazidou et al. Nature Communications
- Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production
- (2012) Zemin Yao et al. CURRENT OPINION IN LIPIDOLOGY
- Apolipoprotein C‐III as a Potential Modulator of the Association Between HDL‐Cholesterol and Incident Coronary Heart Disease
- (2012) Majken K. Jensen et al. Journal of the American Heart Association
- Dual Metabolic Defects Are Required to Produce Hypertriglyceridemia in Obese Subjects
- (2011) Marja-Riitta Taskinen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart Disease
- (2011) Carlos O. Mendivil et al. CIRCULATION
- Development of a sensitive ELISA to quantify apolipoprotein CIII in nonhuman primate serum
- (2011) Yuxin Wang et al. JOURNAL OF LIPID RESEARCH
- Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia
- (2010) Sandrine Caron et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype
- (2010) Chunyu Zheng et al. CIRCULATION
- Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters
- (2010) Ioannis K. Karalis et al. CURRENT MEDICAL RESEARCH AND OPINION
- ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan
- (2009) A. Hiukka et al. DIABETES
- Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome
- (2008) Martin Adiels et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Apolipoprotein CIII and Atherosclerosis
- (2008) Alex Bobik CIRCULATION
- Toll-Like Receptor 2 Mediates Apolipoprotein CIII–Induced Monocyte Activation: Retracted
- (2008) Akio Kawakami et al. CIRCULATION RESEARCH
- Increased Plasma Apolipoprotein C-III Concentration Independently Predicts Cardiovascular Mortality: The Hoorn Study
- (2008) P. G. Scheffer et al. CLINICAL CHEMISTRY
- Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
- (2008) Esther M. M. Ooi et al. CLINICAL SCIENCE
- Structure and Dynamics of Human Apolipoprotein CIII
- (2008) Chinthaka Saneth Gangabadage et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
- (2008) T. I. Pollin et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation